Requires opioid antagonists in student gathering places at colleges and universities; requires college and university emergency medical services to carry and have readily available opioid antagonists.
Impact
This bill significantly impacts existing laws regarding opioid overdose prevention in educational settings. By formally requiring universities and colleges to maintain on-site opioid antagonists and to train personnel to administer these drugs, S08153 aims to address the alarming rise in opioid overdoses among the student population. The implications extend beyond health and safety regulations, reinforcing a proactive approach towards responding to public health emergencies in higher education institutions.
Summary
Bill S08153 mandates the presence of opioid antagonists, such as naloxone, in key locations on college and university campuses in New York State. This legislation aims to enhance the preparedness of educational institutions in handling potential opioid overdose emergencies by requiring that these life-saving medications be readily available in main student gathering places and libraries. Furthermore, it establishes requirements for college and university emergency medical services to ensure they carry these antagonists at all times, facilitating prompt response to such health crises.
Contention
While the bill has garnered support on the grounds of improving student safety, there are concerns regarding the practicality and resources needed for its implementation. Critics may question the adequacy of training for staff and the responsibility it places on educational institutions in an already overwhelmed healthcare landscape. Moreover, discussions surrounding the bill may highlight the need for a comprehensive strategy that includes mental health support and preventative measures to address the underlying issues of substance abuse among students.
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Requires vehicles operated by public transit authorities to contain opioid antagonists and for public transit authorities to train employees on the proper use of opioid antagonists.
Requires vehicles operated by public transit authorities to contain opioid antagonists and for public transit authorities to train employees on the proper use of opioid antagonists.
Requires public institutions and buildings to be equipped with opioid antagonists; directs the commissioner of general services to promulgate regulations to address the appropriate number of opioid antagonists for such buildings based on the size or occupancy of the buildings, the training of personnel and use of opioid antagonists, and any other matter deemed necessary.
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.